271 related articles for article (PubMed ID: 24499954)
21. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
Front Immunol; 2021; 12():638010. PubMed ID: 33868264
[No Abstract] [Full Text] [Related]
22. T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.
Cobos Jiménez V; Wit FW; Joerink M; Maurer I; Harskamp AM; Schouten J; Prins M; van Leeuwen EM; Booiman T; Deeks SG; Reiss P; Kootstra NA;
J Infect Dis; 2016 Jul; 214(2):216-25. PubMed ID: 27073222
[TBL] [Abstract][Full Text] [Related]
23. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration.
Méndez-Lagares G; García-Pergañeda A; del Mar del Pozo-Balado M; Genebat M; Ruiz-Mateos E; García García M; Muñoz-Fernández MÁ; Pacheco YM; Leal M
J Antimicrob Chemother; 2012 May; 67(5):1228-37. PubMed ID: 22287235
[TBL] [Abstract][Full Text] [Related]
24. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
25. HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy.
Xiao J; Qian KL; Cao QH; Qiu CL; Qiu C; Xue YL; Zhang XY; Zhong P; Xu JQ; Li MY; Wang Y
Chin Med J (Engl); 2011 Aug; 124(15):2340-6. PubMed ID: 21933566
[TBL] [Abstract][Full Text] [Related]
26. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
[TBL] [Abstract][Full Text] [Related]
27. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.
Vranjkovic A; Crawley AM; Patey A; Angel JB
J Leukoc Biol; 2011 Apr; 89(4):499-506. PubMed ID: 21177484
[TBL] [Abstract][Full Text] [Related]
28. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
[TBL] [Abstract][Full Text] [Related]
29. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
[TBL] [Abstract][Full Text] [Related]
30. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis.
Marchetti G; Riva A; Cesari M; Bellistrì GM; Gianelli E; Casabianca A; Orlandi C; Magnani M; Meroni L; d'Arminio Monforte A; Mussini C; Cossarizza A; Galli M; Gori A;
HIV Med; 2009 Aug; 10(7):422-31. PubMed ID: 19459995
[TBL] [Abstract][Full Text] [Related]
31. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
32. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
[TBL] [Abstract][Full Text] [Related]
33. The influence of HIV on CD127 expression and its potential implications for IL-7 therapy.
Crawley AM; Angel JB
Semin Immunol; 2012 Jun; 24(3):231-40. PubMed ID: 22421574
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
[TBL] [Abstract][Full Text] [Related]
35. Elevated IP10 levels are associated with immune activation and low CD4⁺ T-cell counts in HIV controller patients.
Noel N; Boufassa F; Lécuroux C; Saez-Cirion A; Bourgeois C; Dunyach-Remy C; Goujard C; Rouzioux C; Meyer L; Pancino G; Venet A; Lambotte O;
AIDS; 2014 Feb; 28(4):467-76. PubMed ID: 24378753
[TBL] [Abstract][Full Text] [Related]
36. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
[TBL] [Abstract][Full Text] [Related]
37. Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection.
Petitjean G; Chevalier MF; Tibaoui F; Didier C; Manea ME; Liovat AS; Campa P; Müller-Trutwin M; Girard PM; Meyer L; Barré-Sinoussi F; Scott-Algara D; Weiss L
AIDS; 2012 Jan; 26(2):139-48. PubMed ID: 22045342
[TBL] [Abstract][Full Text] [Related]
38. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
[TBL] [Abstract][Full Text] [Related]
39. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
40. Immune signatures for HIV-1 and HIV-2 induced CD4
Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
